Novo Nordisk Canada Inc.
Registration:
12
of
20
(2022-09-16
to
2023-01-04)
Policies or Program
- Advocate for the implementation of a federal diabetes and obesity strategy.
- Commemoration of the 100th anniversary of the discovery of insulin in Canada.
- Support the establishment of a life sciences strategy in Canada
Policies or Program, Regulation
- Impact of Patented Medicine Prices Review Board reform on the life sciences sector.
- Date Modified: